127.69USD-1.17%Mkt Cap: 17.00B USDP/E: —Last update: 2026-06-01
Guardant Health, Inc., a precision oncology company, provides blood and tissue tests, and data sets in the United States and internationally. The company offers Guardant360 CDx test, a liquid biopsy test for tumor mutati…
Industry Peers
Diagnostics & Research183.26BUSDP/E 27.1
127.46BUSDP/E 35.0
45.09BUSDP/E 42.1
38.48BUSDP/E 27.4
37.00BUSDP/E 47.9
34.66BCHFP/E 38.1
31.51BUSD—
31.45BUSDP/E 23.4
Indicators:|
Key Statistics
Company
Market Cap17.00B USD
Enterprise Value17.80B USD
Revenue (TTM)1.08B USD
Gross Profit633.01M USD
Net Income (TTM)-416.28M USD
Revenue/Share8.491 USD
Last Price127.69 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees2.5K
CountryUS
SectorHealthcare
IndustryDiagnostics & Research
ISINUS40131M1099
Valuation
P/E (Trailing)—
P/E (Forward)-225.81
PEG—
EV/EBITDA-43.61
EV/Revenue16.48
P/S15.92
P/B-94.18
EPS (TTM)-3.40
EPS (Forward)-0.57
52W Range
38.0793% of range133.97
52W High133.97 USD
52W Low38.07 USD
Profitability
Gross Margin64.46%
Oper. Margin-40.23%
EBITDA Margin-37.79%
Profit Margin-42.39%
ROE419.18%
ROA-20.67%
Growth
Revenue Growth48.30%
Earnings Growth—
Cash Flow & Leverage
Operating CF-184.76M USD
CapEx (TTM)48.31M USD
FCF Margin-7.91%
FCF Yield-0.50%
Net Debt601.80M USD
Net Debt/EBITDA-1.47
Balance Sheet
Debt/Equity-17.22
Current Ratio4.68
Quick Ratio4.25
Book Value/Sh-1.3770 USD
Cash/Share8.316 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating1.4 (Strong Buy)
Target (Mean)131.24 USD
Target Range90.00 USD – 190.00 USD
# Analysts21
Ownership
Shares Out.132.60M
Float127.80M
Insiders4.04%
Institutions105.75%
Short Interest
Short Ratio6.6d
Short % Float10.17%
Short % Out.9.75%
Shares Short12.93M
Short (prev mo.)11.64M
Technical
SMA 5093.55 (+36.5%)
SMA 20088.80 (+43.8%)
Beta1.49
S&P 52W Chg27.94%
Avg Vol (30d)2.10M
Avg Vol (10d)2.64M
Technical Indicators
RSI (14)78.8
MACD9.7768
MACD Signal6.5311
MACD Hist.+3.2457
BB Upper133.30 USD
BB Middle104.45 USD
BB Lower75.60 USD
BB Width55.24%
ATR (14)6.267 USD
Vol Ratio (20d)1.07x